Loading...

Carmen Masson, PhD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentPsychiatry
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-206-8404
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Digital Health Technology Use Among Methadone Maintenance Patients
    NIH/NIDA R21DA038304Jul 1, 2015 - Jun 30, 2017
    Role: Principal Investigator
    Mentoring Early-Career Scientists for Drug Abuse Research Careers
    NIH/NIDA R25DA035163May 1, 2014 - Apr 30, 2019
    Role: Principal Investigator
    Hepatitis Care Coordination in Methadone Treatment
    NIH/NIDA R01DA020781Sep 30, 2006 - Apr 30, 2013
    Role: Principal Investigator
    PREVENTION OF INFECTIOUS DISEASE IN INJECTION DRUG USERS
    NIH/NIDA K01DA000408Mar 20, 1999 - Sep 30, 2004
    Role: Principal Investigator
    REFERRAL SERVICE FOR SUBSTANCE ABUSERS AT RISK FOR AIDS
    NIH/NIDA F32DA005768Mar 27, 1997
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Selected Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. Int J Drug Policy. 2015 Nov; 26(11):1056-63. PMID: 26050614; PMCID: PMC4581906 [Available on 11/01/16].
    2. Guydish J, Masson C, Flentje A, Shopshire M, Sorensen JL. Scientific writing seminar for early-stage investigators in substance abuse research. Subst Abus. 2016 Jan-Mar; 37(1):238-41. PMID: 25893689.
      View in: PubMed
    3. Dhingra L, Perlman DC, Masson C, Chen J, McKnight C, Jordan AE, Wasser T, Portenoy RK, Cheatle MD. Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance. Drug Alcohol Depend. 2015 Apr 1; 149:285-9. PMID: 25735466; PMCID: PMC4391061 [Available on 04/01/16].
    4. Perlman DC, Jordan AE, McKnight C, Young C, Delucchi KL, Sorensen JL, Des Jarlais DC, Masson CL. Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions. J Addict Dis. 2014; 33(4):322-31. PMID: 25299236; PMCID: PMC4275379.
    5. Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen JL, Des Jarlais DC, Perlman DC. Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis. J Subst Abuse Treat. 2014 Apr; 46(4):528-31. PMID: 24462241; PMCID: PMC4019752.
    6. Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Sorensen JL, Des Jarlais DC, Perlman DC. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013 Oct; 103(10):e81-8. PMID: 23947319; PMCID: PMC3853128.
    7. Jordan AE, Masson CL, Mateu-Gelabert P, McKnight C, Pepper N, Bouche K, Guzman L, Kletter E, Seewald RM, Des-Jarlais DC, Sorensen JL, Perlman DC. Perceptions of drug users regarding hepatitis C screening and care: a qualitative study. Harm Reduct J. 2013; 10:10. PMID: 23786800; PMCID: PMC3695813.
    8. Masson CL, Rainey PM, Moody DE, McCance-Katz EF. Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individuals. Am J Addict. 2014 Jan-Feb; 23(1):34-40. PMID: 24313239; PMCID: PMC3998818.
    9. Masson CL, Shopshire MS, Sen S, Hoffman KA, Hengl NS, Bartolome J, McCarty D, Sorensen JL, Iguchi MY. Possible barriers to enrollment in substance abuse treatment among a diverse sample of Asian Americans and Pacific Islanders: opinions of treatment clients. J Subst Abuse Treat. 2013 Mar; 44(3):309-15. PMID: 22985677; PMCID: PMC3545039.
    10. Dhingra L, Masson C, Perlman DC, Seewald RM, Katz J, McKnight C, Homel P, Wald E, Jordan AE, Young C, Portenoy RK. Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend. 2013 Feb 1; 128(1-2):161-5. PMID: 22951068; PMCID: PMC3546120.
    11. Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):283-93. PMID: 21854270; PMCID: PMC3361073.
    12. Masson CL, Sorensen JL, Grossman N, Sporer KA, Des Jarlais DC, Perlman DC. Organizational issues in the implementation of a hospital-based syringe exchange program. Subst Use Misuse. 2010 May; 45(6):901-15. PMID: 20397875; PMCID: PMC3378397.
    13. Chen T, Masson CL, Sorensen JL, Greenberg B. Residential treatment modifications: adjunctive services to accommodate clients on methadone. Am J Drug Alcohol Abuse. 2009; 35(2):91-4. PMID: 19259872; PMCID: PMC3558978.
    14. Sorensen JL, Andrews S, Delucchi KL, Greenberg B, Guydish J, Masson CL, Shopshire M. Methadone patients in the therapeutic community: a test of equivalency. Drug Alcohol Depend. 2009 Feb 1; 100(1-2):100-6. PMID: 19013724; PMCID: PMC2606930.
    15. Chiao C, Morisky DE, Ksobiech K, Masson CL, Malow RM. Clinic appointment attendance for sexually transmitted infection screening among Filipina sex workers: a multilevel analysis. AIDS Care. 2007 Oct; 19(9):1166-70. PMID: 18058401; PMCID: PMC3130545.
    16. Masson CL, Sorensen JL, Perlman DC, Shopshire MS, Delucchi KL, Chen T, Sporer K, Des Jarlais D, Hall SM. Hospital- versus community-based syringe exchange: a randomized controlled trial. AIDS Educ Prev. 2007 Apr; 19(2):97-110. PMID: 17411413; PMCID: PMC3853200.
    17. Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction. 2006 Dec; 101(12):1797-804. PMID: 17156179.
      View in: PubMed
    18. Wasserman DA, Sorensen JL, Delucchi KL, Masson CL, Hall SM. Psychometric evaluation of the Quality of Life Interview, Brief Version, in injection drug users. Psychol Addict Behav. 2006 Sep; 20(3):316-21. PMID: 16938069.
      View in: PubMed
    19. Sorensen JL, Masson CL, Delucchi K, Sporer K, Barnett PG, Mitsuishi F, Lin C, Song Y, Chen T, Hall SM. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol. 2005 Dec; 73(6):1026-35. PMID: 16392976.
      View in: PubMed
    20. Carey J, Perlman DC, Friedmann P, Kaplan WM, Nugent A, Deutscher M, Masson CL, Des Jarlais DC. Knowledge of hepatitis among active drug injectors at a syringe exchange program. J Subst Abuse Treat. 2005 Jul; 29(1):47-53. PMID: 15979531.
      View in: PubMed
    21. Masson CL, Sorensen JL, Phibbs CS, Okin RL. Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders. AIDS Care. 2004 Aug; 16(6):744-55. PMID: 15370062.
      View in: PubMed
    22. Masson CL, Barnett PG, Sees KL, Delucchi KL, Rosen A, Wong W, Hall SM. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction. 2004 Jun; 99(6):718-26. PMID: 15139870.
      View in: PubMed
    23. Sorensen JL, Masson CL, Perlman DC. HIV/hepatitis prevention in drug abuse treatment programs: guidance from research. Sci Pract Perspect. 2002 Jul; 1(1):4-11. PMID: 18567957; PMCID: PMC2851052.
    24. Masson CL, Sorensen JL, Batki SL, Okin R, Delucchi KL, Perlman DC. Medical service use and financial charges among opioid users at a public hospital. Drug Alcohol Depend. 2002 Mar 1; 66(1):45-50. PMID: 11850135.
      View in: PubMed
    25. Gilbert DG, McClernon FJ, Rabinovich NE, Plath LC, Masson CL, Anderson AE, Sly KF. Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. J Consult Clin Psychol. 2002 Feb; 70(1):142-52. PMID: 11860040.
      View in: PubMed
    26. Clark HW, Masson CL, Delucchi KL, Hall SM, Sees KL. Violent traumatic events and drug abuse severity. J Subst Abuse Treat. 2001 Mar; 20(2):121-7. PMID: 11306214.
      View in: PubMed
    27. Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000 Mar 8; 283(10):1303-10. PMID: 10714729.
      View in: PubMed
    28. Masson CL, Gilbert DG. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers. J Behav Med. 1999 Dec; 22(6):589-604. PMID: 10650538.
      View in: PubMed
    29. Perlman DC, Des Jarlais DC, Salomon N, Masson CL. Preventing opportunistic infections in HIV-infected injection drug users. JAMA. 1997 Dec 3; 278(21):1743-4. PMID: 9388148.
      View in: PubMed
    30. Masson C, Gilbert DG. Cardiovascular responses to a quantified dose of nicotine as a function of personality and nicotine tolerance. J Behav Med. 1990 Oct; 13(5):505-21. PMID: 2273527.
      View in: PubMed
    Carmen's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP